{"name": "Esperance Pharmaceuticals",
 "permalink": "esperance-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/esperance-pharmaceuticals",
 "homepage_url": "http://www.esperancepharma.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "admin@esperancepharma.com",
 "phone_number": "225-615-8944",
 "description": "",
 "created_at": "Thu Jun 02 03:18:35 UTC 2011",
 "updated_at": "Thu Jun 02 03:26:10 UTC 2011",
 "overview": "\u003Cp\u003EEsperance Pharmaceuticals is developing a new class of targeted anticancer drugs that selectively kill cancer cells without harming normal cells. Targeting occurs through binding to specific receptors on the cell\u0026#8217;s surface. The drugs kill even those cells known to be resistant to chemotherapeutic drugs.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       30],
      "assets/images/resized/0013/7401/137401v1-max-150x150.jpg"],
     [[250,
       50],
      "assets/images/resized/0013/7401/137401v1-max-250x250.jpg"],
     [[419,
       84],
      "assets/images/resized/0013/7401/137401v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$7.5M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "http://money.msn.com/business-news/article.aspx?feed=PR\u0026Date=20110601\u0026ID=13713866\u0026topic=TOPIC_FINANCING\u0026isub=1",
    "source_description": "Esperance Pharmaceuticals Completes $7.5 Million Series B Financing",
    "raised_amount": 7500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 6,
    "funded_day": 1,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Louisiana Fund I",
         "permalink": "louisiana-fund-i",
         "image":
          {"available_sizes":
            [[[150,
               30],
              "assets/images/resized/0025/8815/258815v1-max-150x150.png"],
             [[250,
               50],
              "assets/images/resized/0025/8815/258815v1-max-250x250.png"],
             [[280,
               56],
              "assets/images/resized/0025/8815/258815v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Themelios Ventures",
         "permalink": "themelios-ventures",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Advantage Capital Partners",
         "permalink": "advantage-capital-partners",
         "image":
          {"available_sizes":
            [[[150,
               85],
              "assets/images/resized/0002/1156/21156v2-max-150x150.jpg"],
             [[205,
               117],
              "assets/images/resized/0002/1156/21156v2-max-250x250.jpg"],
             [[205,
               117],
              "assets/images/resized/0002/1156/21156v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Louisiana Technology Innovation Fund",
         "permalink": "louisiana-technology-innovation-fund",
         "image":
          {"available_sizes":
            [[[150,
               27],
              "assets/images/resized/0025/8205/258205v1-max-150x150.png"],
             [[250,
               45],
              "assets/images/resized/0025/8205/258205v1-max-250x250.png"],
             [[450,
               81],
              "assets/images/resized/0025/8205/258205v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Louisiana Emerging Technology Center",
    "address2": "340 East Parker Blvd.",
    "zip_code": "70803",
    "city": "Baton Rouge",
    "state_code": "LA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}